InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Shannon Elaine Mary. Director active across 1 company, notably TAKEDA PHARMACEUTICAL CO LTD. Aggregated, 3 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €368k. Activity tracked since 1 July 2026. The latest transaction was disclosed on 11 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations